If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Completion of £350m share buyback programme

Today 07:00

RNS Number : 4039L
Aviva PLC
08 July 2026
 

 

 

 

8 July 2026

 

Aviva plc

Completion of £350m share buyback programme

 

Aviva plc ("Aviva") announces that it has successfully completed its £350m share buyback programme (the "Programme") which was notified to the market on 5 March 2026.

 

As a result of the Programme, Aviva acquired 56,721,704 ordinary shares at an average price of 617.05 pence per share.

 

As at close of business on 7 July 2026, Aviva had 3,001,654,143 issued ordinary shares admitted to trading, 203,460 of which are pending cancellation under the Programme. Aviva does not hold any ordinary shares in treasury and therefore, net of ordinary shares pending cancellation, Aviva has 3,001,450,683 ordinary shares admitted to trading.

 

-ends-

 

LEI: YF0Y5B0IB8SM0ZFG9G81

 

Enquiries:

Media:

Andrew Reid

+44 (0)7800 694 276

Analysts:

Michael O'Hara

+44 (0)7387 234 388

Giles White

+44 (0)7385 011 249

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAKOBDCBKDKOK

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS